• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Institute of Medicine (US) Forum on Neuroscience and Nervous System Disorders. Sex Differences and Implications for Translational Neuroscience Research: Workshop Summary. Washington (DC): National Academies Press (US); 2011.

Cover of Sex Differences and Implications for Translational Neuroscience Research

Sex Differences and Implications for Translational Neuroscience Research: Workshop Summary.

Show details

Institute of Medicine Forum on Neuroscience and Nervous System Disorders*

ALAN LESHNER (Chair), American Association for the Advancement of Science

HUDA AKIL, University of Michigan

MARC BARLOW, GE Healthcare, Inc.

MARK BEAR, Massachusetts Institute of Technology

DAVID BREDT, Eli Lilly and Company

DANIEL BURCH, CeNeRx Biopharma

DENNIS CHOI, Emory University

TIMOTHY COETZEE, National Multiple Sclerosis Society

DAVID COHEN, Columbia University

EMMELINE EDWARDS, NIH Neuroscience Blueprint (since February 2010)

RICHARD FRANK, GE Healthcare, Inc.

JOHN GRIFFIN, Johns Hopkins University School of Medicine

MYRON GUTTMAN, National Science Foundation (since June 2010)

RICHARD HODES, National Institute on Aging

KATIE HOOD, Michael J. Fox Foundation for Parkinson’s Research

STEVEN E. HYMAN, Harvard University

THOMAS INSEL, National Institute of Mental Health

STORY LANDIS, National Institute of Neurological Disorders and Stroke

HUSSEINI MANJI, Johnson & Johnson Pharmaceutical Research and Development, LLC

EVE MARDER, Brandeis University

DAVID MICHELSON, Merck Research Laboratories

JONATHAN MORENO, University of Pennsylvania School of Medicine

MICHAEL OBERDORFER, NIH Neuroscience Blueprint (until January 2010)

KATHIE L. OLSEN, Association of Public and Land-Grant Universities

ATUL PANDE, GlaxoSmithKline, Inc.

MENELAS PANGALOS, Pfizer Inc

STEVEN PAUL, Weill Cornell Medical College

WILLIAM POTTER, FNIH Neuroscience Biomarker Steering Committee

PAUL SIEVING, National Eye Institute

RAE SILVER, Columbia University

WILLIAM THIES, Alzheimer’s Association

NORA VOLKOW, National Institute on Drug Abuse

KENNETH WARREN, National Institute on Alcohol Abuse and Alcoholism

FRANK YOCCA, AstraZeneca Pharmaceuticals

STEVIN H. ZORN, Lundbeck USA

CHARLES ZORUMSKI, Washington University School of Medicine

IOM Staff

BRUCE M. ALTEVOGT, Forum Director

SARAH L. HANSON, Associate Program Officer (until June 2010)

DIANA E. PANKEVICH, Associate Program Officer (since October 2010)

LORA K. TAYLOR, Senior Project Assistant

ANDREW POPE, Director, Board on Health Sciences Policy

IOM forums and roundtables do not issue, review, or approve individual documents. The responsibility for the published workshop summary rests with the workshop rapporteurs and the institution.

Footnotes

*

IOM forums and roundtables do not issue, review, or approve individual documents. The responsibility for the published workshop summary rests with the workshop rapporteurs and the institution.

Copyright © 2011, National Academy of Sciences.
Bookshelf ID: NBK53390
PubReader format: click here to try

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (612K)

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...